SCAI Therapeutics
The dating app that does it all - make friends, meet people, or find a date.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
KRW31.4b | Series B | ||
| Total Funding | 000k | ||
Scai Therapeutics operates in the biotechnology sector, focusing on the discovery and development of innovative cancer treatments. The company leverages artificial intelligence (AI) and machine learning to identify and develop novel drug candidates, aiming to improve the efficiency and success rate of cancer drug discovery. Scai Therapeutics primarily serves pharmaceutical companies and research institutions, providing them with advanced tools and insights to expedite their drug development processes. The company operates on a B2B (business-to-business) model, generating revenue through partnerships, licensing agreements, and collaborative research projects. By integrating cutting-edge technology with deep scientific expertise, Scai Therapeutics aims to transform the landscape of cancer treatment and bring new hope to patients worldwide.
Keywords: AI-driven, drug discovery, cancer therapies, biotechnology, pharmaceutical partnerships, machine learning, novel drug candidates, B2B model, collaborative research, innovative treatments.